Popular topics to explore
Pfizer Shares Extend Winning Streak as Quant Mutual Fund Raises Stake
Pfizer shares extended gains for a third straight session after Quant Mutual Fund acquired a ₹131.25 crore stake in the company.
Pfizer Limited PFIZER share prices remained in focus on Friday 21 Aug 2026 as the stock extended its winning s…
19th Aug · SEBI-Registered Analyst
Short Term Investing with M.J Research · 19th Aug
High delivery stock
Symbol Delivered Qty
ASTERDM 62324493
APOLLOTYRE 1551426
RAILTEL 1004625
ATGL 1378460
HSCL 7592497
AIIL 443706
JUBLPHARMA 712444
GLAXO 438502
SWIGGY 8661820
PFIZER 111827
SOBHA 109386
IGL 1962541
PFOCUS 884325
AADHARHFC 670510
ASTERDM
The India-listed shares of Pfizer Limited have shown active momentum, closing at ₹4,874.80
PFIZER The India-listed shares of Pfizer Limited have shown active momentum, closing at ₹4,874.80 on the National Stock Exchange. Positive sentiment spilled over from its global parent company, which raised its lower-end full-year 2026 re…
Major Products and TreatmentsThe company owns several high-profile medicines and vaccines used globally
PFIZER Corporate Status: Publicly traded Indian subsidiary of Pfizer Inc., listed on the BSE and ***** Mumbai, ***** Business: Marketing, manufacturing, and distribution of pharmaceuticals and vaccines in ***** Brands: Becosules (multivit…
Pfizer Inc. is a leading American multinational pharmaceutical and biotechnology corporation headquartered in New York City
PFIZER Pfizer Inc. is a leading American multinational pharmaceutical and biotechnology corporation headquartered in New York City. Founded in 1849, it has grown into one of the world's largest pharmaceutical companies, widely recognized…
Pfizer India Q1 FY26: Profit Growth, Margin Expansion
PFIZER
Social Media–Ready Post
📌 Pfizer India Q1 FY26 Results
Net Profit: ₹2.04B vs ₹1.9B (YoY) ⬆️
EBITDA: ₹2.47B vs ₹2.1B (YoY) ⬆️
EBITDA Margin: 37.9% vs 34.8% (YoY) ⬆️
📊 Fundamentals & Ratios
Revenue: ~₹25.2B
Net Profit: ~₹7.2…
CIPLA
Cipla climbed 3.05 percent to close at Rs 1,461.90 on Monday, outperforming amid broad-based buying in pharmaceutical stocks ahead of the company's first-quarter FY27 earnings, scheduled to be announced on July 23. Analysts expect Cipla to…
USFDA Nod Opens New Growth Avenue for AUROPHARMA
AUROPHARMA remained in focus after receiving final USFDA approval for Tofacitinib Tablets (5 mg and 10 mg), a generic version of Pfizer’s Xeljanz used to treat rheumatoid arthritis and other autoimmune disorders. The approval allows the co…
AUROPHARMA Gains After Securing USFDA Approval for Generic Tofacitinib Tablets
AUROPHARMA 's shares moved higher after the company announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and commercialize Tofacitinib Tablets (5 mg and 10 mg) in the United States…
PFIZER Pfizer India – Strong Healthcare Franchise Backed by Global Innovation
PFIZER Pfizer Limited is one of India's leading multinational pharmaceutical companies, benefiting from a strong portfolio of established brands, global research capabilities, and exposure to high-growth therapeutic segments. Backed by Pf…
Pfizer Shares in Spotlight Today – May 13, 2026
PFIZER is expected to attract market attention on Wednesday, May 13, following the release of its Q4 FY26 financial results. The company reported a significant drop in net profit, which declined 39.6% year-on-year to Rs 199.8 crore from Rs…
PFIZER Board approved audited FY26 results on May 12, 2026, reporting revenue from operations of ₹2,519.65 crore and net profit of ₹722.43 crore. The Board recommended a final dividend of ₹75 per share (750%), with the record date set as J…
📢 Q4 Earnings Alert: Stocks in Focus Today – 12 May 2026
Market watchers, keep these counters on your radar as they announce their Q4 FY26 results today:
DRREDDY
TATAPOWER
BERGEPAINT
DIXON (India)
INOXINDIA
MFSL
MOBIKWIK
NAZARA
PFIZER
TORNTPOWER
!V-Guard Industries
⚡ Earning…
📊 Market Outlook for Tomorrow – NIFTY & BANK NIFTY
📊 Closing Snapshot NIFTY 50: 23,815 (-360 pts) BANK NIFTY: 54,439 (-870 pts) India VIX: 18.51 (+9.93%) FII Activity: Net Sellers (~₹8,437 Cr) DII Activity: Net Buyers (~₹5,939 Cr) 🔹 NIFTY Outlook NIFTY closed weak below key short-term av…
GRANULES
Granules India Ltd. is a leading manufacturer of active pharmaceutical ingredients (API) and pharmaceutical formulations. The company was founded in 1989 and is headquartered in Hyderabad, India. Granules has a strong presence in the global…
HDFCLIFE Companies with 1-Year Returns
Here’s a list of companies along with their 1-year performance:👇
🔻 Negative 1-Year Returns:
* TCS (–29.31%)
* Wipro (–32.79%)
* Syngene International (–37.38%)
* P & G Hygiene (–16.21%)
* ACC (…
Pfizer presents a compelling long-term investment case anchored in scale, innovation, and capital strength.
PFIZER
Despite post-pandemic revenue normalization, the company retains one of the deepest pipelines in large-cap pharma, targeting high-value therapeutic areas including oncology, vaccines, immunology, and rare diseases.
The acquisitio…
PFIZER - learning Breakout
PFIZER is breaking out from more of a downward channel which was making lower high and lower low, now stock gaining and sustaining above the resistance trendline. If it sustains, the retracement towards previous swing high 6000 can be se…
10th Feb · SEBI-Registered Analyst
Short Term Investing with M.J Research · 10th Feb
High delivery stocks as on 10/02/2026
Symbol Delivered Qty PFIZER 94472 PRAJIND 3370399 SUNTV 912030 BERGEPAINT 1651690 CAMPUS 1493611 AUROPHARMA 3390797 LINDEINDIA 107585 BATAINDIA 255312 FINCABLES 379420 BIRLACORPN 140567 NIACL 667843 BALRAMCHIN 443232 RAMCOCEM 327004 NEULAND…
Pfizer Limited (Weekly Chart): Descending Channel Within a Broader Range
PFIZER
🔍 Technical Analysis
1. Price Structure
The chart shows a broad multi-year range with repeated reactions at upper and lower bands.
Recent price action is corrective in nature, unfolding as a downward-sloping move after a prior…
